BIOAI is an AI-powered biotech innovation project founded by a passionate biotechnology student. We’re on a mission to accelerate drug discovery by blending the power of artificial intelligence with molecular biology.
From molecule prediction to target validation, BIOAI is exploring how automation, machine learning, and big data can revolutionize early-stage drug development.
As we build our journey in public, we aim to share insights, connect with like-minded innovators, and lay the foundation for a next-gen CRDMO (Contract Research, Development & Manufacturing Organization).
Join us as we turn molecules into miracles.
Company Details
- Employees
- 1
- Founded
- 2025
- Address
- Washington, District Of Columbia 20017, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- for early-stage biotech teams.
- HQ
- Washington, district of Columbia
Bioai – Molecules To Miracles Questions
Bioai – Molecules To Miracles's LinkedIn profile is https://www.linkedin.com/company/bioai%E2%80%93molecules
Bioai – Molecules To Miracles has
1 employees.
View email and phone details for 1
employees at Bioai – Molecules To Miracles.
Bioai – Molecules To Miracles's industry is
Biotechnology Research
Bioai – Molecules To Miracles's top competitors are
Fanda Scientific,
Mclean Community Center,
Bioai,
Crowley Center For Regenerative Biotherapeutics & Atventurecenter,
Vesiculab.
Bioai – Molecules To Miracles's categories are Biotechnology Research
Bioai – Molecules To Miracles's founding year is 2025
